In this Issue

In the nearly five years since the Generic Drug User Fee Agreement was enacted under the Food and Drug Administration Safety and Innovation Act of 2012, through the FDA’s Office of Generic Drug, GDUFA has generated some $1.5 billion in user fees and has seen 1,992 approvals issued.

(To view the full Category Review, click here.)

Today’s diabetes patients represent a coveted consumer base for retail pharmacy no matter how you characterize that diabetes spend. For example, consumers with diabetes spend 35% more on OTC products than the average consumer, noted Jeff Gregori, group VP consumer and shopper analytics for Nielsen, during a presentation at the 2016 National Association of Chain Drug Stores Total Store Expo.

While price, taste and convenience continue to be key influencers of food-shopping behavior, U.S. consumers are increasingly prioritizing health and wellness in their decision-making, and this is especially true when it comes to beverages.

(To view the full Category Review, click here.)

What do you get when you pair the world’s largest database on diabetes metrics with a big data super computer that will mine, analyze and optimize that data?

(To view the full Diabetes Report, click here.)

ST. LOUIS — Anheuser-Busch recently launched Best Damn Cherry Cola, the second national offering from Best Damn Brewing Co. According to the company, Best Damn Cherry Cola is aged on whole cherries after brewing for a harder take on the timeless taste of cherry cola. “Best Damn Cherry Cola continues to build our portfolio of bold, approachable and down-to-earth beers,” said Rash-mi Patel, VP share of throat, Anheuser-Busch.

Cardiff University in October found that smartphone apps could offer patients with Type 2 diabetes a highly effective method of self-managing their condition.

(To view the full Diabetes Report, click here.)

There aren’t many good-news stories when it comes to loss prevention.

While tampons and menstrual cups have coexisted on the market for decades, presently there is a movement toward the use of menstrual cups, such as Diva International’s DivaCup. According to Research and Markets, the global menstrual cups market is projected to grow at a CAGR of 4% between 2016 and 2020.

(To view the full OTC Women's Health Report, click here.)